Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$64.27 - $69.9 $2,056 - $2,236
32 New
32 $2,000
Q4 2022

Feb 13, 2023

BUY
$51.15 - $57.45 $1,074 - $1,206
21 New
21 $1,000
Q1 2021

May 24, 2021

SELL
$57.98 - $73.08 $38,846 - $48,963
-670 Closed
0 $0
Q4 2020

Feb 09, 2021

SELL
$62.61 - $71.29 $11,019 - $12,547
-176 Reduced 20.8%
670 $48,000
Q3 2020

Nov 16, 2020

BUY
$51.39 - $72.41 $43,475 - $61,258
846 New
846 $59,000
Q2 2020

Aug 10, 2020

SELL
$39.55 - $54.65 $1,384 - $1,912
-35 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$34.75 - $45.85 $1,216 - $1,604
35 New
35 $1,000
Q1 2018

Apr 23, 2018

SELL
$31.93 - $39.54 $12,772 - $15,816
-400 Closed
0 $0
Q2 2017

Aug 17, 2017

BUY
N/A
400
400 $17,000

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.29B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.